Intelligent Bio Solutions P/E Ratio

Intelligent Bio Solutions (GBS) currently reports a P/E ratio of -0.19. That is below the Healthcare sector average of 70.94. Use the charts on this page to explore Intelligent Bio Solutions's P/E ratio history and peer comparisons.

Intelligent Bio Solutions's P/E ratio of -0.19 is lower than the Healthcare sector average of 70.94. That is roughly 100.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Intelligent Bio Solutions's market price to a fundamental measure such as earnings, sales, or book value. At -0.19, GBS can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -0.19, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 70.94. From there, open related valuation or income-statement pages for Intelligent Bio Solutions, and consider following GBS for alerts when major investors trade the stock.

Intelligent Bio Solutions is classified in the Healthcare sector. On P/E ratio, it currently shows -0.19 versus a sector average near 70.94. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GBS with unrelated industries.